Immunology & Autoimmune
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | $0.5t | $232.35 | +1.8% | 8.0M |
 ABBV | ABBVIE INC. | $384.7b | $226.50 | +0.7% | 6.2M |
 AMGN | Amgen Inc | $181.8b | $349.61 | +1.2% | 3.5M |
 BMY | Bristol-Myers Squibb Co. | $116.8b | $57.00 | +0.7% | 9.6M |
 REGN | Regeneron Pharmaceuticals Inc | $64.5b | $635.40 | +1.1% | 975.8K |
 ROIV | Roivant Sciences Ltd. Common Shares | $21.6b | $28.57 | -3.3% | 4.6M |
 IBRX | ImmunityBio, Inc. Common Stock | $7.9b | $6.92 | -5.1% | 13.8M |
 IMVT | Immunovant, Inc. Common Stock | $6.8b | $31.07 | -4.9% | 872.1K |
 PTGX | Protagonist Therapeutics, Inc | $6.4b | $97.33 | -5.3% | 887.4K |
 SYRE | Spyre Therapeutics, Inc. Common Stock | $6.4b | $73.60 | -6.2% | 1.5M |
 APGE | Apogee Therapeutics, Inc. Common Stock | $6.2b | $86.89 | -4.4% | 1.3M |
 TGTX | TG Therapeutics, Inc. | $5.8b | $40.13 | -1.1% | 1.8M |
 APLS | Apellis Pharmaceuticals, Inc. Common Stock | $5.2b | $41.04 | +0.0% | 68.6M |
 DNTH | Dianthus Therapeutics, Inc. Common Stock | $5.1b | $80.47 | -4.3% | 835.9K |
 ORKA | Oruka Therapeutics, Inc. Common Stock | $3.5b | $60.14 | -3.4% | 1.3M |
 RCUS | Arcus Biosciences, Inc. | $3.2b | $22.54 | -8.7% | 1.0M |
 ALMS | Alumis Inc. Common Stock | $2.8b | $19.06 | -6.5% | 1.4M |
 ARQT | Arcutis Biotherapeutics, Inc. Common Stock | $2.7b | $21.22 | -3.3% | 1.2M |
 VERA | Vera Therapeutics, Inc. Class A Common Stock | $2.5b | $32.28 | -3.3% | 1.5M |
 CLDX | Celldex Therapeutics, Inc | $2.5b | $28.64 | -4.3% | 1.3M |
 NKTR | Nektar Therapeutics | $2.2b | $57.39 | -3.2% | 1.0M |
 AUPH | Aurinia Pharmaceuticals Inc | $2.0b | $15.82 | -3.4% | 1.3M |
 ADMA | ADMA Biologics, Inc. | $1.8b | $7.97 | -0.1% | 2.5M |
 ANAB | AnaptysBio, Inc. Common Stock | $1.7b | $50.37 | -2.5% | 612.0K |
 BHVN | Biohaven Ltd. | $1.7b | $10.86 | -4.7% | 2.0M |
 MLTX | MoonLake Immunotherapeutics Class A Ordinary Shares | $1.4b | $17.91 | -4.3% | 538.6K |
 SEPN | Septerna, Inc. Common Stock | $1.4b | $31.19 | -0.6% | 211.7K |
 ZBIO | Zenas BioPharma, Inc. Common Stock | $1.2b | $17.43 | -5.2% | 494.1K |
 DBVT | DBV Technologies S.A. | $1.1b | $16.65 | -5.3% | 273.5K |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.0b | $11.10 | -5.3% | 1.2M |
 JBIO | Jade Biosciences, Inc. Common Stock | $1.0b | $16.91 | -4.7% | 2.6M |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $1.0b | $13.51 | -6.4% | 753.8K |
 ANNX | Annexon, Inc. Common Stock | $0.9b | $5.28 | -3.1% | 1.8M |
 XNCR | Xencor, Inc. | $0.9b | $11.78 | -2.0% | 862.6K |
 AVTX | Avalo Therapeutics, Inc. Common Stock | $0.8b | $13.09 | -3.9% | 1.8M |
 EVMN | Evommune, Inc. | $0.8b | $19.92 | -3.7% | 417.4K |
 IMMX | Immix Biopharma, Inc. Common Stock | $0.6b | $7.90 | -6.2% | 1.3M |
 ACRS | Aclaris Therapeutics, Inc. | $0.6b | $4.37 | -7.2% | 929.0K |
 CLYM | Climb Bio, Inc. Common Stock | $0.6b | $10.54 | -3.4% | 985.6K |
 CABA | Cabaletta Bio, Inc. Common Stock | $0.6b | $3.23 | -7.8% | 4.3M |
 RIGL | Rigel Pharmaceuticals Inc. (New) | $0.6b | $29.98 | -0.9% | 498.4K |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $0.5b | $7.45 | -6.3% | 617.4K |
 STTK | Shattuck Labs, Inc. Common Stock | $456.2m | $4.59 | -4.4% | 1.1M |
 UPB | Upstream Bio, Inc. Common Stock | $455.0m | $7.04 | -5.3% | 672.6K |
 IPSC | Century Therapeutics, Inc. Common Stock | $441.9m | $2.14 | -2.7% | 1.9M |
 ZURA | Zura Bio Limited Class A Ordinary Shares | $421.3m | $3.40 | -7.2% | 5.0M |
 FBRX | Forte Biosciences, Inc. Common Stock | $390.5m | $16.61 | -0.4% | 408.7K |
 ENTA | Enanta Pharmaceuticals, Inc | $382.7m | $11.26 | -4.0% | 135.1K |
 PALI | Palisade Bio, Inc. Common Stock | $368.4m | $1.74 | -9.8% | 4.3M |
 IFRX | InflaRx N.V. Common Stock | $353.5m | $1.84 | -8.0% | 1.6M |